Optos plc has received 510(k) clearance from the FDA for microperimetry as part of the OptosOCT SLO.
News
All series
All News
Advertisement
Gene therapy is making headway in inherited retinal diseases that were previously thought to be untreatable.
Advertisement
Advertisement
Trending on Modern Retina
1
From AI to injury patterns: Insights from emerging ophthalmic research
2
FLORetina 2025: Reframing retinal disease through the lens of choroidal health
3
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
4
FLORetina 2025: Remotely managing patients with neovascular age-related macular degeneration
5
